CRYSTALLIC FORMS OF LYSYLOXIDASE-LIKE PROTEIN 2 INHIBITOR AND METHODS FOR PRODUCING

摘要

This document describes the crystalline forms of the pharmaceutically acceptable salts of the lysyl oxidase-like protein 2 (LOXL2) (3- (4- (aminomethyl) -6- (trifluoromethyl) pyridin-2-yloxy) phenyl) ((3R, 4R) -3- fluoro-4-hydroxypyrrolidin-1-yl) methanone. Methods for preparing a LOXL2 inhibitor, pharmaceutical compositions and drugs containing a LOXL2 inhibitor, and methods for using a LOXL2 inhibitor in the treatment of conditions, diseases, or disorders associated with LOXL2 activity are also described.